Disease burden and treatment patterns of paroxysmal nocturnal hemoglobinuria in Japan: a real-world survey. [PDF]
Sakurai M +10 more
europepmc +1 more source
Optimizing Care in Patients with Paroxysmal Nocturnal Hemoglobinuria: Managing Suboptimal Response and Uncontrolled Disease. [PDF]
Bienz M +3 more
europepmc +1 more source
Clinical Profile, Humanistic and Economic Burden of Paroxysmal Nocturnal Hemoglobinuria in Patients Treated With C5 Inhibitors. [PDF]
Gandhi S +9 more
europepmc +1 more source
C3 mutations and poor pegcetacoplan response in paroxysmal nocturnal hemoglobinuria. [PDF]
Rodríguez de Córdoba S +8 more
europepmc +1 more source
Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry. [PDF]
Röth A +8 more
europepmc +1 more source
Improved Iron Overload with Pegcetacoplan in Eculizumab-Experienced Patients with Paroxysmal Nocturnal Hemoglobinuria. [PDF]
Shammo J +4 more
europepmc +1 more source
Paroxysmal Nocturnal Hemoglobinuria in a Young Adult Woman: A Representative Case of Recurrent Intravascular Hemolysis. [PDF]
Pera R +4 more
europepmc +1 more source
Population PK-PD Modeling of Danicopan Add-On Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab or Eculizumab. [PDF]
Chen J +4 more
europepmc +1 more source
Myeloproliferative neoplasms with clinically relevant paroxysmal nocturnal hemoglobinuria: clinical correlations and outcomes. [PDF]
Faldu P +6 more
europepmc +1 more source
Successful Birth After First-Trimester Ravulizumab Exposure in a Patient With Paroxysmal Nocturnal Hemoglobinuria: A Case Report. [PDF]
Morioka T +12 more
europepmc +1 more source

